When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 17, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Tomasza Nocznickiego 31, 01-918 Warszawa.

What is the share capital?

The share capital of the company is PLN 109,980 (approx. $29,708).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of USD 47,443, representing an increase of 215.5% compared to 2024.

Yes, the company recorded a net profit of USD 18,469 in 2025.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to USD 9,256 in 2025, representing 50% of all operating expenses.

OgenS.A. in liquidation

KRS: NIP: REGON:

Overview

Status

Deleted

Activity period

2019-01-17 – 2026-09-21

Activity description

Ogen offers individual genetic tests based on a saliva sample collected at home. The reports cover predispositions related to diet, sports, beauty, health, medication metabolism, immunity, and sleep and stress; results are available after several weeks, with prices starting at PLN 599.

Registered address

ul. Tomasza Nocznickiego 31, 01-918 Warszawa, Poland

Social media

Electronic delivery address

AE:PL-29194-95870-SAISW-23

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs voivodeship

Revenue

This companyUSD 47.44kMedianUSD 155.47kAverageUSD 5.90m

Net profit

This companyUSD 18.47kMedianUSD 2.41kAverageUSD 343.33k

Operating costs

This companyUSD 18.60kMedianUSD 130.86kAverageUSD 5.69m

Assets

This companyUSD 11.61kMedianUSD 162.40kAverageUSD 14.21m

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

16 notices recorded in the Court and Commercial Gazette (MSiG).

Publication date	Event
Jul 23, 2026	Shareholders' meeting convened
Oct 28, 2025	Shareholders' meeting convened
Jun 11, 2025	Call to creditors
May 27, 2025	Liquidation opened
Apr 4, 2025	Shareholders' meeting convened

Public aid

Grant date	Purpose	Gross amount	Granting body
May 4, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	——	Polski Fundusz Rozwoju S.A.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Beneficial owners

Person	Rights
Tomasz Maciej Purwin (70)	Osoba sprawująca kontrolę nad spółką posiadającą większość udziałów w podmiocie zgłaszającym

Change history

Date	Event
2026-09-21	Struck off the register
2026-08-17	Liquidation ended / withdrawn
2025-05-09	Name change (Ogen → Ogen Spółka Akcyjna W Likwidacji)
2025-04-28	Liquidation opened
2023-01-20	Share capital change (107,482.00 PLN → 109,979.60 PLN)

FAQ

Last updated: 2026-10-03